Natural Medicine Center, Korea Institute of Science and Technology, Gangneung, Gangwon-do 210-340, Republic of Korea.
J Nat Prod. 2012 Sep 28;75(9):1648-51. doi: 10.1021/np3003854. Epub 2012 Sep 6.
A new lucentamycin analogue, lucentamycin E (5), was isolated from the culture broth of the marine-derived actinomycete Nocardiopsis lucentensis, strain CNR-712. The absolute stereostructure of 5 was assigned by comprehensive analyses of NMR data and by application of the advanced Marfey's method. The planar structure of 5 was analogous to lucentamycins A-D, whereas the olefin geometry of the 3-methyl-4-ethylideneproline moiety was found to be E, opposite of that previously reported. Consequently, a reinvestigation of the olefin geometries of the 3-methyl-4-ethylideneproline residues of lucentamycins A-D showed that the olefin geometries of the substituted proline functionalities must be revised to (2S,3R,E)-3-methyl-4-ethylideneproline.
一种新的亮菌素类似物,亮菌素 E(5),从海洋来源放线菌诺卡氏菌属 CNR-712 的发酵液中分离得到。通过全面分析 NMR 数据和应用先进的 Marfey 方法,确定了 5 的绝对立体结构。5 的平面结构与亮菌素 A-D 类似,而 3-甲基-4-亚乙基脯氨酸部分的烯烃几何形状被发现为 E,与之前报道的相反。因此,对亮菌素 A-D 中 3-甲基-4-亚乙基脯氨酸残基的烯烃几何形状进行了重新研究,结果表明取代脯氨酸官能团的烯烃几何形状必须修订为(2S,3R,E)-3-甲基-4-亚乙基脯氨酸。